NNMT overexpression has been reported to decrease drug sensitivity and enhance chemoresistance in breast cancer, esophageal squamous cell carcinoma, and cell lines of colorectal cancer and melanoma26–29. The gene discussed is NNMT; the disease is colorectal cancer.